ScreenPoint Medical and Ferrum Health have partnered to offer ScreenPoint’s Transpara Breast AI Suite on Ferrum Health's Model Hub.
Ferrum Health’s vendor-neutral clinical AI governance suite validates and monitors clinical AI models within a health system's owned, secure environment. The platform enables healthcare organizations to transition from one-off AI deployments to a single foundation to deploy, manage, and measure AI across service lines while maintaining full control of data, security, and evidence, the companies said.
Transpara Breast AI is designed to be a “second reader” for both 2D and 3D mammography, and includes Transpara Detection, Transpara Density, and Temporal Comparison. According to ScreenPoint, Transpara Detection improved cancer detection rates by up to 29% overall in a randomized controlled trial across variables including breast density, patient ethnicity, and radiologist experience level.
![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
